← All stocks

MYOMO, INC.

MYO Net buying
CIK 0001369290 #4562 in the set updated 17 Sep 2026
Bought (120 mo)
$1.97M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$796.57K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$796.57K
21 of 22 sales
Net
+$1.17M
+$1.17M against sales at will

By person

17 insiders · 73 transactions
4.8×

Paul R. Gudonis holds only 4.8 times base salary in stock. $1.82M of shares against $375.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul R. Gudonis last reported holding, valued at $1.27, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
KIRK THOMAS F
Director
$1.17M (18)
+$1.17M
772,569
$981.86K
GUDONIS PAUL R
Chief Executive Officer
$436.57K (11)
+$436.57K
1,434,679
$1.82M
Kovelman Harry
Chief Medical Officer
$5.00K (1)
$411.00K (9)
−$406.00K
90,245
$114.69K
+1,171%
Mitchell Micah
Chief Commercial Officer
$5.00K (1)
$325.25K (4)
−$320.25K
130,738
$166.15K
Manko Joseph M. Jr.
Director
$173.91K (2)
+$173.91K
2,388,479
$3.04M
+13.3%
HENRY DAVID A
Chief Financial Officer
$88.28K (5)
+$88.28K
470,163
$597.53K
Getz Heather C
Director
$64.93K (2)
+$64.93K
210,458
$267.47K
Crowley Thomas Aloysius Jr.
Director
$3.23K (2)
$39.17K (8)
−$35.94K
154,931
$196.90K
Morris Milton Mayo
Director
$15.87K (1)
$21.15K (1)
−$5.28K
208,391
$264.84K
Naft Jonathan
VP, General Manager
(1)
$0.00
22,298
$28.34K
Sanghi Steve
Director
(1)
$0.00
570,621
$725.20K
FEBBO WILLIAM J
Director
123,704
$157.22K
Knapp Amy K.
Director
91,645
$116.47K
GOLDWASSER RALPH A
Chief Financial Officer
78,619
$99.92K
+690.5%
Mendelsohn Davie
VP, Sales
36,099
$45.88K
+98.7%
CONNEIGHTON CLIFF
Chief Marketing Officer
17,738
$22.54K
Green Brandon M
Chief Medical Officer
1,664
$2.11K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Kovelman Harry
1 Dec 2023
Chief Medical Officer
Sold on a plan
8,333
no price

What was left out

Form 4 filings counted 245
Amendments (4/A) skipped 17
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 21
Transactions with no price 9
Shares from compensation/vesting 4,878,135
Sales filed before the plan box existed 3
History held since 13 Jun 2017